Market Cap

aXichem AB Market Capitalization:

kr86.2 Million

SEK as of Jan. 1, 2024

US$8.6 Million

business aXichem AB Company Profile

aXichem AB Main Stock Listing

OMX: AXIC.A

Market Capitalization History of aXichem AB

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $461.52 B
Vertex Pharmaceuticals Incorporated $107.23 B
Regeneron Pharmaceuticals, Inc. $100.01 B
CSL Limited $94.74 B
Marinomed Biotech AG $73.23 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $586.39 B
UnitedHealth Group $504.47 B
Novo Nordisk $461.52 B
Johnson & Johnson $387.50 B
Merck $296.51 B

Yearly evolution of aXichem AB market cap

Date Market Cap YoY Change
Jan. 1, 2024 kr86.2 M -59.75%
Jan. 1, 2023 kr214.1 M -36.17%
Jan. 1, 2022 kr335.5 M -53.81%
Jan. 1, 2021 kr726.3 M -40.29%
Jan. 1, 2020 kr1.22 B 9.21%
Jan. 1, 2019 kr1.11 B 343.30%
Jan. 1, 2018 kr251.3 M 182.73%
Jan. 1, 2017 kr88.9 M 13.37%
Jan. 1, 2016 kr78.4 M -56.04%
Jan. 1, 2015 kr178.3 M -32.25%
Jan. 1, 2014 kr263.2 M 119.30%
Jan. 1, 2013 kr120.0 M -20.00%
Jan. 1, 2012 kr150.0 M

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +269.94%

$10,000 in May 2023 would now be $36,994 by following this algorithm daily at market close.

Boost your stocks returns with Disfold AI... Now!

Try Disfold AI for FREE

aXichem AB Categories

Sweden languages Healthcare languages Biotechnology
Sweden Healthcare Sweden Biotechnology

Stocks & Indices

aXichem AB has the following listings and related stock indices.


Stock: OMX: AXIC.A

Stock: FSX: A6X

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.